Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
ROE: Strong ReturnsExpanding
Percentile Rank56
3Y CAGR-39.2%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-39.2%/yr
vs -3.4%/yr prior
Acceleration
-35.8pp
Decelerating
Percentile
P56
Within normal range
vs 3Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
202510.40%+205.5%
2024-9.85%-407.0%
20233.21%-93.1%
202246.29%+154.2%
2021-85.35%-65.0%
2020-51.74%+28.0%
2019-71.81%-235.1%
201853.15%-26.5%
201772.32%-22.4%
201693.16%-